J&J collaborations

Johnson & Johnson Innovative Medicine and Multiple Myeloma

Johnson & Johnson Innovative Medicine’s goal is to fundamentally alter the way cancer is understood, diagnosed and managed. We are committed to finding innovative ways to fight cancer, including for smouldering and active multiple myeloma, and our primary efforts focus on treatment and prevention solutions.

We are driven by our commitment to patients, working side-by-side with healthcare stakeholders, to offer solutions based on trust and transparency. Below are a number of Johnson & Johnson Innovative Medicine’s initiatives that you may find interesting or helpful.

My Myeloma - Ready for the Steps Ahead

My Myeloma - Ready for the Steps Ahead is a documentary that captures the journey of multiple myeloma patients from the Central European and Baltics region. It was filmed in partnership with multiple myeloma patient organisations from Hungary, Croatia, Slovakia, Serbia and Slovenia. It is a heartfelt tribute to the patients, patient organisations and healthcare professionals who have battled tirelessly against this disease.

References

[1]

Myeloma UK. Myeloma: an introduction. Available at: https://www.myeloma.org.uk/wp-content/uploads/2018/03/Myeloma-UK-Myeloma-An-Introduction-1.pdf Last accessed: February 2025.

[2]

International Myeloma Foundation. Concise review of the disease and treatment options. 2017 edition. Available at: https://imf-d8-prod.s3.us-west-1.wasabisys.com/resource/ConciseReview.pdf Last accessed: February 2025.

[3]

Memorial Sloan Kettering Cancer Center. Multiple Myeloma Symptoms. https://www.mskcc.org/cancer-care/types/multiple-myeloma/multiple-myeloma-symptoms Last accessed: February 2025.

[4]

Gavriatopoulou M, et al. Metabolic Disorders in Multiple Myeloma. Int J Mol Sci. 2021;22(21):11430.

[5]

American Cancer Society. Multiple myeloma: causes, risk factors, and prevention. Available at: https://www.cancer.org/content/dam/CRC/PDF/Public/8739.00.pdf. Last accessed: February 2025.

[6]

Myeloma Patients Europe. Multiple Myeloma – A Patients’ Guide. Available at: www.mpeurope.org/files/Patients-guide-mpe-web-version-V2.pdf. Last accessed: February 2025.

[7]

International Myeloma Foundation. Understanding MGUS and Smoldering Multiple Myeloma, and Active Myeloma. Available at: https://www.myeloma.org/what-are-mgus-smm-mm Last accessed: February 2025.

[8]

[9]

Moreau P, et al. Ann Oncol. 2017;28 (Suppl 4):iv52-iv61

[10]

WebMD. Smoldering Multiple Myeloma. Available at: https://www.webmd.com/cancer/multiple-myeloma/smoldering-multiple-myeloma. Last accessed: February 2025.

[11]

American Cancer Society. About multiple myeloma. Available at: https://www.cancer.org/cancer/types/multiple-myeloma/about/what-is-multiple-myeloma.html. Last accessed: February 2025.

[12]

Hughes, D, Yong, K, Ramasamy, K et al. Diagnosis and management of smouldering myeloma: A British Society for Haematology Good Practice Paper. British Journal of Haematology. 2024: 1193-2016.

[13]

NHS Inform. Multiple Myeloma – About multiple myeloma. Available at: https://www.nhsinform.scot/illnesses-and-conditions/cancer/cancer-types-in-adults/multiple-myeloma

[14]

Bahlis NJ, Lazarus HM. Multiple myeloma-associated AL amyloidosis. Bone Marrow Transplantation. 2006;38;7-15.

[15]

Vaxman I, Gatt ME. Smouldering multiple myeloma: To seek or not to seek? To treat or not to treat. That is the question. Br J Haematol. 2024; 204(4): 1141–1142.

Get In Touch